Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
Primary Purpose
Lung Cancer, Tobacco Use Disorder
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
caregiver-related intervention or procedure
questionnaire administration
quality-of-life assessment
radiography
Sponsored by
About this trial
This is an interventional diagnostic trial for Lung Cancer focused on measuring non-small cell lung cancer, small cell lung cancer, tobacco use disorder
Eligibility Criteria
DISEASE CHARACTERISTICS:
- Patients over 60 seeing a participating General Practitioner
Currently smokes 10 or more pack years, meeting at least one of the following criteria:
- New or altered cough of any duration reported to primary care
- Increased breathlessness or wheezing (with or without purulent sputum)
Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:
- Cough
- Chest/shoulder pain
- Dyspnea
- Weight loss
- Chest signs
- Hoarseness
- Finger clubbing
- Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)
- Cervical/supraclavicular lymphadenopathy
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- No chest x-ray within in past 3 months
- No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics
Sites / Locations
Outcomes
Primary Outcome Measures
Prevalence of extra-NICE symptoms in patients consulting in UK general practice
Proportion of patients who agree to participate in the trial
Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers
Secondary Outcome Measures
Best way to train general practitioners to identify and recruit eligible patients into the trial
Most effective method of presenting the trial (and randomization) to patients
Barriers to recruitment and how to overcome those barriers
Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
False-positive and false-negative rates for chest x-rays
Full Information
NCT ID
NCT01344005
First Posted
April 27, 2011
Last Updated
August 23, 2013
Sponsor
Wales Cancer Trials Unit
1. Study Identification
Unique Protocol Identification Number
NCT01344005
Brief Title
Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
Official Title
A Pilot Clinical Trial Looking at the Effect on Lung Cancer Diagnosis of Giving a CXR to Smokers Aged Over 60 With Chest Symptoms
Study Type
Interventional
2. Study Status
Record Verification Date
April 2011
Overall Recruitment Status
Unknown status
Study Start Date
June 2011 (undefined)
Primary Completion Date
June 2013 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Wales Cancer Trials Unit
4. Oversight
5. Study Description
Brief Summary
RATIONALE: Diagnostic procedures, such as an urgent chest x-ray, may help in planning cancer treatment. It is not yet known whether standard medical care is more effective than an urgent x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.
PURPOSE: This randomized clinical trial is studying standard medical care to see how well it works compared with an urgent chest x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.
Detailed Description
OBJECTIVES:
Primary
To determine the prevalence of extra-NICE symptoms in patients consulting in UK general practice.
To determine the proportion of patients who agree to participate in the trial.
To determine the proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers.
Secondary
To determine the best way to train general practitioners to identify and recruit eligible patients into the trial.
To determine the most effective method of presenting the trial (and randomization) to patients.
To determine the barriers to recruitment and how to overcome those barriers.
To determine the best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays.
To determine the best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'.
To determine the stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer.
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.
Arm A: Patients are managed as per the National Institute for Health and Clinical Excellence (NICE) guidelines.
Arm B: Patients are referred for an urgent chest x-ray according to extra-NICE guidelines.
General practitioners from South East Wales are surveyed to assess their level of interest in the proposed full trial. For the feasibility study, 20 South East Wales general practices and 6 South Yorkshire general practices are selected. General practitioners are trained to recruit all patients who fulfill the extra-NICE criteria as well as those who do not.
Patients complete questionnaires (HADS, EQ-5D, and ICECAP[O]) at baseline and at 2 months to measure quality of life and health economic analysis of the cost-effectiveness of extra-NICE guidelines.
Peer Reviewed and Funded or Endorsed by Cancer Research UK.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer, Tobacco Use Disorder
Keywords
non-small cell lung cancer, small cell lung cancer, tobacco use disorder
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Masking
None (Open Label)
Allocation
Randomized
Enrollment
386 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
caregiver-related intervention or procedure
Intervention Type
Other
Intervention Name(s)
questionnaire administration
Intervention Type
Procedure
Intervention Name(s)
quality-of-life assessment
Intervention Type
Procedure
Intervention Name(s)
radiography
Primary Outcome Measure Information:
Title
Prevalence of extra-NICE symptoms in patients consulting in UK general practice
Title
Proportion of patients who agree to participate in the trial
Title
Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers
Secondary Outcome Measure Information:
Title
Best way to train general practitioners to identify and recruit eligible patients into the trial
Title
Most effective method of presenting the trial (and randomization) to patients
Title
Barriers to recruitment and how to overcome those barriers
Title
Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
Title
Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
Title
Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
Title
False-positive and false-negative rates for chest x-rays
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS:
Patients over 60 seeing a participating General Practitioner
Currently smokes 10 or more pack years, meeting at least one of the following criteria:
New or altered cough of any duration reported to primary care
Increased breathlessness or wheezing (with or without purulent sputum)
Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:
Cough
Chest/shoulder pain
Dyspnea
Weight loss
Chest signs
Hoarseness
Finger clubbing
Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)
Cervical/supraclavicular lymphadenopathy
PATIENT CHARACTERISTICS:
Not specified
PRIOR CONCURRENT THERAPY:
No chest x-ray within in past 3 months
No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Neal, MD
Organizational Affiliation
North Wales Clinical School
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
35313926
Citation
Prout H, Tod A, Neal R, Nelson A. Maximising recruitment of research participants into a general practice based randomised controlled trial concerning lung diagnosis-staff insights from an embedded qualitative study. Trials. 2022 Mar 21;23(1):225. doi: 10.1186/s13063-022-06125-y.
Results Reference
derived
PubMed Identifier
30075741
Citation
Prout HC, Barham A, Bongard E, Tudor-Edwards R, Griffiths G, Hamilton W, Harrop E, Hood K, Hurt CN, Nelson R, Porter C, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Neal RD, Nelson A. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials. 2018 Aug 4;19(1):419. doi: 10.1186/s13063-018-2803-4.
Results Reference
derived
PubMed Identifier
28072761
Citation
Neal RD, Barham A, Bongard E, Edwards RT, Fitzgibbon J, Griffiths G, Hamilton W, Hood K, Nelson A, Parker D, Porter C, Prout H, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Hurt CN. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. Br J Cancer. 2017 Jan;116(3):293-302. doi: 10.1038/bjc.2016.414. Epub 2017 Jan 10.
Results Reference
derived
PubMed Identifier
24279296
Citation
Hurt CN, Roberts K, Rogers TK, Griffiths GO, Hood K, Prout H, Nelson A, Fitzgibbon J, Barham A, Thomas-Jones E, Edwards RT, Yeo ST, Hamilton W, Tod A, Neal RD. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials. 2013 Nov 26;14:405. doi: 10.1186/1745-6215-14-405.
Results Reference
derived
Learn more about this trial
Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
We'll reach out to this number within 24 hrs